Elenestinib
- Generic Name
- Elenestinib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H29FN10O
- CAS Number
- 2505078-08-8
- Unique Ingredient Identifier
- 6FBM4CP6RK
- Background
Elenestinib is a selective KIT inhibitor.
- Associated Conditions
- -
- Associated Therapies
- -
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-06-02
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Blueprint Medicines Corporation
- Target Recruit Count
- 463
- Registration Number
- NCT04910685
- Locations
- 🇫🇷
CHU Grenoble, Grenoble Cedex 9, France
🇫🇷CHU de Limoges, Limoges Cedex, France
🇫🇷CHU de Nantes, Nantes, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath